Ronald G. Eidell, Director at NEOPHARM INC (NEOL), bought 4,900 shares at $10.20 ($50K) on 2006-01-05, disclosed to the SEC on 2006-01-06.
Open-market purchase of $50k NEOL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.